Clinical Trial Update: Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating vascular reactivity in idiopathic pulmonary fibrosis was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Fibrosis

Snippet

Sponsor: Alicia Gerke | Conditions: Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-11-13